Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-24 @ 9:25 PM
NCT ID:
NCT03213132
Eligibility Criteria:
Inclusion Criteria:
* age 55 and over
* sleep onset latency (SOL) and/or wake after sleep onset (WASO) (\>30 minutes for at least 3 nights/week)
* insomnia symptoms for ≥ 3 months
* no more than 6.5 hours of sleep per night
* the sleep disturbance (or associated daytime fatigue) must cause significant distress or - impairment in social, occupational, or other areas of functioning
* regular access (at least 2/week) and willingness to use a computer and the Internet and check email
* ability to read and speak English
* resident of the US
Exclusion Criteria:
* irregular sleep schedules that prevent the ability to follow intervention recommendations(i.e., with usual bedtimes outside of 8:00pm to 2:00am or arising time outside of 4:00am to 10:00am)
* current psychological treatment for insomnia
* initiated psychological or psychiatric treatment within past 3 months
* screen positive for a history of psychotic or bipolar disorder; and current severe depression, high risk of suicide, substance use (alcohol, drug) disorder within the past year
* symptoms suggestive of untreated sleep disorders other than insomnia (e.g., obstructive sleep apnea, restless legs syndrome, periodic limb movement disorder)
* presence of severe cognitive impairment
* presence of uncontrolled medical condition that is deemed to interfere with the study procedures, or put the study participant at undue risk
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
55 Years
Study:
NCT03213132
Study Brief:
Protocol Section:
NCT03213132